转录因子
疾病
阿尔茨海默病
生物
癌症研究
计算生物学
医学
遗传学
内科学
基因
作者
Zhuo Qu,Jiachen Sun,Wannian Zhang,Jian-Qiang Yu,Zhenyuan Miao
标识
DOI:10.1016/j.freeradbiomed.2020.06.028
摘要
Oxidative stress is considered as one of the pathogenesis of Alzheimer’s disease (AD) and plays an important role in the occurrence and development of AD. Nuclear factor erythroid 2 related factor 2 (NRF2) is a key regulatory of oxidative stress defence. There is growing evidence indicating the relationship between NRF2 and AD. NRF2 activation mitigates multiple pathogenic processes involved in AD by upregulating antioxidative defense, inhibiting neuroinflammation, improving mitochondrial function, maintaining proteostasis, and inhibiting ferroptosis. In addition, several NRF2 activators are currently being evaluated as AD therapeutic agents in clinical trials. Thus, targeting NRF2 has been the focus of a new strategy for prevention and treatment of AD. In this review, the role of NRF2 in AD and the NRF2 activators advanced into clinical and preclinical studies will be summarized. • NRF2 is regulated by multiple mechanisms. • NRF2 plays a critical role in the pathogenesis of AD. • NRF2 modulates oxidative stress, neuroinflammation, proteostasis, mitochondrial function, and ferroptosis in AD. • Targeting NRF2 is a promising strategy to treat AD.
科研通智能强力驱动
Strongly Powered by AbleSci AI